4basebio PLC (FRA:88Q)

Germany flag Germany · Delayed Price · Currency is EUR
13.00
0.00 (0.00%)
Last updated: Jun 5, 2025
-21.21%
Market Cap 168.74M
Revenue (ttm) 1.13M
Net Income (ttm) -14.91M
Shares Out n/a
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 186
Open 13.00
Previous Close 13.00
Day's Range 13.00 - 13.00
52-Week Range 11.80 - 20.60
Beta n/a
RSI 50.45
Earnings Date May 9, 2025

About 4basebio

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccine... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 84
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 88Q
Full Company Profile

Financial Performance

In 2024, 4basebio's revenue was 933,000, an increase of 84.39% compared to the previous year's 506,000. Losses were -12.33 million, 60.9% more than in 2023.

Financial numbers in GBP Financial Statements

News

There is no news available yet.